Bayer has delayed a planned sale of its animal health unit to private equity interests in order to explore a merger with US firm Elanco, claims Reuters. Citing three separate anonymous sources ...

The rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the German company set to make $7.6 billion from the sale. The divestment will make Elanco the ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...

Bayer Animal Health, and the Burroughs Wellcome Fund. The approximate start date for the project is September 16, 2006. A report is expected to be released at the end of the project in approximately ...

New Product Manager Dr. Jan Koesling has over 20 years of experience in animal health, with a particular focus on aquatic animals in ponds and cages. Product Team – INVE Aquaculture: Eva Werbrouck ...